TAM (Treatments and Medicines) NHS Highland
Important: Formulation and dosage details
Formulation:
Tablets 5mg, 10mg
Dosage:
Hypertension or angina: initially 5mg once daily, maximum 10mg once daily.
Calcium-channel blockers - dihydropyridine (Formulary)
Refer to the Stable angina management guideline.
Important: Therapy notes
Long-acting formulations of nifedipine are recommended for angina or long-term management of hypertension but are off-label for use in Raynaud's phenomenon.
Modified-release preparations of nifedipine:
- prescribe by brand name
- select the most cost-effective brand when initiating therapy
- hospitals will only stock some brands; contact Pharmacy to identify brands currently available
- patients should continue on the same brand
- consider once-daily preparations in new patients and when medicine is being changed.
Important: Formulation and dosage details
Formulation:
Modified release tablets 20mg, 30mg, 40mg, 60mg (once daily dosing)
Important: Formulation and dosage details
Formulation:
Modified release tablets 10mg, 20mg (twice daily dosing)
Important: Therapy notes
MHRA advice: Drug-name confusion: reminder to be vigilant for potential errors (January 2018) (www.gov.uk)
Important: Formulation and dosage details
Formulation:
Tablets 30mg (hospital use only)
Dosage:
Prevention of ischaemic neurological defects following aneurysmal subarachnoid haemorrhage: by mouth, 60mg every 4 hours, starting within 4 days of event and continued for 21 days.
Important: Formulation and dosage details
Formulation:
Intravenous infusion 10mg/50mL (hospital use only)
Dosage:
Aneurysmal subarachnoid haemorrhage: refer to BNF and guidance.